Horan Capital Management’s Zimmer Biomet ZBH Stock Holding History

Horan Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,128	Closed	-$112K	–	69
2015 Q4	$112K	Hold	1,128	–	–	0.03%	63
2015 Q3	$102K	Buy	+1,128	New	+$113K	0.03%	63

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Horan Capital Management's ZBH Position: Q1 2016 in Review

Horan Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2016, closing a stake of 1,128 shares — an estimated $112K sold.

Horan Capital Management first reported a position in ZBH in Q3 2015 and held it in 2 quarters. The position peaked at $112K in Q4 2015. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

Horan Capital Management reported no remaining Zimmer Biomet position as of Q1 2016 after selling out during the quarter.
Horan Capital Management sold 1,128 Zimmer Biomet shares in Q1 2016, an estimated $112K.
Horan Capital Management first reported a position in Zimmer Biomet in Q3 2015 and held it in 2 quarters.
Horan Capital Management's Zimmer Biomet position peaked at $112K in Q4 2015.
746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on Horan Capital Management's 13F filing for Q1 2016, filed 19 Apr 2016.